Through an analysis of tumor samples collected over time from patients with advanced melanoma, a Ludwig Cancer Research study has identified a set of preexisting conditions in tumors that predict whether such patients are likely to respond to a personalized immunotherapy known as adoptive T cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL).
The US Biosecure Act threatens to destabilise the pharmaceutical industry – Pharmaceutical Technology
In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act,